Address
360 North Pastoria Avenue
Sunnyvale, CA 94085
United States of America (the)
Phone
800 436 0826
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
327
First IPO Date
October 11, 2024
| Name | Title | Pay | Year Born |
| Xingjuan Chao | Co-Founder, President, Chief Executive Officer & Director | 1.28M | 1981 |
| Josef Parvizi | Co-Founder, Chief Medical Advisor & Director | 242,525 | 1969 |
| Raymond Woo | Chief Technology Officer | 657,085 | 1983 |
| Scott Blumberg | Chief Financial Officer | 677,065 | N/A |
| David Foehr | Senior Vice President of Finance | 0 | N/A |
| Brian Price | Senior Vice President of Marketing | 0 | N/A |
| Dan Rogy | Senior Vice President of Operations | 0 | N/A |
| Joseph S. Manni | Chief Revenue Officer | 0 | 1974 |
| Baharan Kamousi | Senior Vice President of Data Science | 0 | N/A |
| Kim McKeon | Vice President of People & Culture | 0 | N/A |
| Louisa Daniels | General Counsel | 0 | 1958 |
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.